HeartFlow

Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.

HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.

At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.

Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com


 

Identifying patients that can benefit from the CCTA and FFRct pathway

319 views
June 12, 2023

Dr. Matthew Budoff discusses identifying patients who can benefit from the CCTA and FFRct pathway, He also reviews how CCTA can assist in diagnosing coronary artery disease in underserved patient populations and assist in preventive care, and how this pathway can help patients to avoid missed diagnosis or having repeated and unnecessary tests or invasive procedures.

Comments 0
Login to view comments. Click here to Login